Nomogram predicting No-ER rates for intermediate‐ to high‐risk DTC pati - Evidencio
Nomogram predicting No-ER rates for intermediate‐ to high‐risk DTC patients receiving RAT.
In recent years, nomograms have emerged as powerful predictive tools in oncology research. By integrating multiple prognostic factors, nomograms provide a visual representation of individualized risk assessments, allowing clinicians to estimate the probability of specific outcomes for patients. By leveraging a large cohort of DTC patients who underwent surgical resection and received RAT, we aim to construct and validate a nomogram that incorporates relevant prognostic factors. The findings from this study hold significant potential for improving clinical management and decision-making in DTC patients. The development of a nomogram will enhance our ability to predict the clinical response to surgery and RAT, leading to more tailored treatment strategies and optimized patient outcomes.
Auteurs: Lu Lu
Versie: 1.7
  • Publiek
  • Nucleaire geneeskunde
  • {{ modelType }}
  • Details
  • Valideer algoritme
  • Bewaar invoer
  • Laad invoer
Weergave
Eenheden

{{ section.title }}

{{ section.description }}

Bereken het resultaat

Vul meer parameters in om de berekening uit te voeren

Predicted No-ER risk

{{ resultSubheader }}
{{ $t('download_result_availability') }}
{{ chart.title }}
Resultaat interval {{ additionalResult.min }} tot {{ additionalResult.max }}

Conditionele informatie

Based on the risk factors from multivariate logistic regression analysis, we constructed a nomogram for predicting the No-ER rate. Each variable was assigned a score on a scale. By adding scores for each of the selected variables, a total score was obtained. Then a vertical line was dropped down from the total points row to estimate the risk of No-ER. The nomogram showed that Tg level, TgAb level, and CLNM were the top 3 contributors to the No-ER, followed by ATA  risk and bilateral foci

{{ file.classification }}
PRO
Notitie
Notities zijn alleen zichtbaar in de resultaat download en worden niet opgeslagen door Evidencio

Dit algoritme wordt verstrekt voor educatieve, opleidings- en informatieve doeleinden. Het mag niet worden gebruikt ter ondersteuning van medische besluitvorming, of om medische of diagnostische diensten te verlenen. Lees onze volledige disclaimer.

Onderliggende algoritmes Onderdeel van
Opmerkingen
Opmerking
Vul een opmerking in.
Opmerkingen zijn voor iedereen zichtbaar

Algoritme feedback

Nog geen feedback 1 Opmerking {{ model.comments.length }} Opmerkingen
Op {{ comment.created_at }} {{ comment.user.username }} een niet langer geregistreerde auteur schreef:
{{ comment.content }}
logo

Log a.u.b. in om de Evidencio print-functies te gebruiken

Om de Evidencio print-functies te kunnen gebruiken dient u ingelogt te zijn.
Indien u nog geen Evidencio Community Account heeft kunt u eenvoudig een persoonlijk account aanmaken op:

https://www.evidencio.com/registration

Print rapport - Voorbeelden {{ new Date().toLocaleString() }}


Evidencio Community Account voordelen


With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.


Disclaimer: Predictie algoritmes dienen enkel ter ondersteuning en naslag geraadpleegd te worden en zijn geen vervanging voor medische besluitvorming door professionals.
Evidencio v3.38 © 2015 - 2025 Evidencio. Alle rechten voorbehouden